Gareth Thomas and the Fight Against HIV Stigma

Retired rugby star Gareth Thomas, known for his battle with HIV, recently spent time in Rio de Janeiro’s Ipanema Beach to support the ‘Tackle HIV’ campaign. Thomas became an influential voice for those living with HIV after he revealed his positive status in 2019.

According to Thomas, fear and ignorance still surround HIV. His visit was part of the International AIDS Conference, aiming to raise awareness and understanding about living with the virus.

“People are still afraid of those three letters,” Thomas noted, referring to HIV.

His message struck a chord with Welton Gabriel, a 36-year-old event organizer. Gabriel recalled when he discovered he was HIV positive 12 years ago, leading many friends to sever ties. Although he now works as an activist fighting HIV stigma in Brazil, the emotional toll of that time lingers.

Gabriel’s diagnosis was complicated by a resistant strain of HIV, but effective treatment brought the infection under control after several months. Despite the progress, disclosing his status resulted in further isolation.

Discrimination remains a significant barrier in Brazil, which has approximately 1.1 million people living with HIV. UNAIDS Brazil reports that over half of these individuals have faced discrimination.

Despite advances, preconceived notions about HIV persist. Brazil’s public health system provides free medications that enable normal lives for those with HIV, yet stigma persists.

Gabriel now works with Barong, an organization that conducts testing and education on HIV. He emphasizes that discrimination often stems from fear. Despite medical advancements, Gabriel says the cultural perception of HIV as a death sentence remains largely unchanged since the death of Brazilian singer Cazuza in 1990.

At a ‘Tackle HIV’ event, teenagers were educated on HIV realities. Thomas highlighted the lack of awareness about modern treatments that can prevent and control HIV.

“Many people don’t know that you can live a normal, happy, healthy life if you start medication straight away,” Thomas explained.

In Brazil, 27% of those diagnosed with HIV are identified only after the disease progresses to advanced AIDS, resulting in preventable deaths. In 2024, over 9,000 AIDS-related deaths were recorded.

Challenges persist even with timely diagnosis, as not all patients maintain treatment regimens. Government data shows that 82% of those with HIV are on antiretroviral drugs, missing the UN target of 95%.

Stigma from healthcare providers also deters individuals from seeking treatment. Gabriel notes that many fear judgment when taking their medication, causing discontinuation.

Societal attitudes towards LGBT communities in Brazil complicate matters. Proposals to ban discussions on sex and gender, alongside high violence rates against sexual minorities, exacerbate the issue.

In healthcare, this discrimination often frames HIV as linked to immorality, contributing to stigma. Fabiana de Oliveira, another activist, shared similar challenges. After disclosing her HIV status, she lost her fiancé and faced community judgment.

Amid these cultural challenges, Brazil also leads innovations like lenacapavir, a potent injectable drug for HIV, reflecting the dual nature of its HIV narrative.

Despite skepticism about education’s role in changing perceptions, Gabriel acknowledges the potential for change. As he educated those around him about HIV, relationships improved, underscoring the importance of awareness.